DCAF12 and myasthenia gravis: The innovation of this study is that by combining ssGSEA and WGCNA bioinformatic analysis methods to explore the differences in immune cell types between MG and healthy control from the microarray dataset, we then determine the expression and clinical significance of identified immune-related hub genes the DCAF12 and HSPA1A mRNA in MG.